Congenital Heart Disease Research
A heart that started differently deserves a lifetime of care that keeps pace with it.
Current research in the Division of Pediatric Cardiology
Fontan Registry
The Fontan Registry is a prospective, observational study of individuals with single ventricle congenital heart disease living with a Fontan circulation. This study will collect biological, psychological and physiological data on individuals living with Fontan as they age to watch for patterns in when, how and why complications occur in some individuals but not others. This is an open-ended registry with no cap on enrollments.
Genetic Determinants of Response to Infant SVT Therapy
Supraventricular tachycardia (SVT) is the most common heart rhythm abnormality in infants with structurally normal hearts. When infants are diagnosed with SVT and therapy is determined to be indicated, this is typically addressed by starting medications via a process of trial and error. We are performing genetic testing on these patients to evaluate for ability to target specific medications to patients based on their genetic profile in order to maximize effectiveness and minimize side effects and cost.
Our Partnership with the Andra Heart Foundation
Andra Heart is a Foundation aimed to SAVE THE WORLD, ONE HEART AT A TIME. WE partner closely with Andra Heart who have generously provided pilot funding for congenital heart disease research and our annual visiting professor program.
Visiting Professor 2026
Our annual series brings in speakers for 2 days to share their expertise in pediatric and adult congenital cardiology. Our speakers enhance clinical understanding, foster networking, and offer career mentorship, and inspire students and faculty alike with deeper insights into their specialized knowledge area. This year, James F. Cnota, MD, a fetal cardiologist, explores the complex relationship between congenital heart disease, pregnancy outcomes, and placental development.